Nefazodone Generics Stay On Market Following FDA Analysis Of Serzone Withdrawal

Bristol's voluntary withdrawal of the antidepressant was not due to safety or effectiveness reasons, FDA says. This distinction allows generic versions of Serzone to remain on the market and may help Bristol in its upcoming liability lawsuits.